Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Long Term Debt 2020–2025
Celldex Therapeutics Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Celldex Therapeutics Inc. long term debt as of December 31, 2025: 784,000, a 66.79% decrease year-over-year.
- Celldex Therapeutics Inc. long term debt for 2025 were 784,000, a 66.79% decrease from 2024.
- Celldex Therapeutics Inc. long term debt for 2024 were 2.4M, a 154.42% increase from 2023.
- Celldex Therapeutics Inc. long term debt for 2023 were 928,000, a 64.14% decrease from 2022.
- Celldex Therapeutics Inc. long term debt for 2022 were 2.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Celldex Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2024 | $2 |
| 2023 | $1 |
| 2022 | $3 |
| 2021 | $1 |
| 2020 | $2 |
Celldex Therapeutics Inc. Long Term Debt — FAQ
Celldex Therapeutics Inc. (CLDX) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's long term debt history?
The chart and table above show Celldex Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.